Nova Mentis Life Science Corp.

CNSX: NOVA


Canadian symbol: NOVA.CN
US symbol: NMLSF

Currency in CAD

Valuation Measures

Market Cap (intraday) 55.78M
Enterprise Value 36.06M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)504.16
Price/Book (mrq)1.58
Enterprise Value/Revenue 3528.21
Enterprise Value/EBITDA 7-3.89

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-12.50%
S&P500 52-Week Change 343.61%
52 Week High 30.4400
52 Week Low 30.0900
50-Day Moving Average 30.1270
200-Day Moving Average 30.2002

Share Statistics

Avg Vol (3 month) 3243.68k
Avg Vol (10 day) 3186.32k
Shares Outstanding 560.88M
Implied Shares Outstanding 6N/A
Float 77.26M
% Held by Insiders 15.98%
% Held by Institutions 13.44%
Shares Short (Apr. 14, 2021) 45.26k
Short Ratio (Apr. 14, 2021) 40.03
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.01%
Shares Short (prior month Mar. 14, 2021) 475.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-13,633.64%

Management Effectiveness

Return on Assets (ttm)-16.74%
Return on Equity (ttm)-423.90%

Income Statement

Revenue (ttm)11.47k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-78.80%
Gross Profit (ttm)1.73k
EBITDA -1.56M
Net Income Avi to Common (ttm)-23.25M
Diluted EPS (ttm)-0.4520
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.14M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.91
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-856.53k
Levered Free Cash Flow (ttm)-876.4k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
NOVA.CN
Nova Mentis Life Science
3 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
5.98%% of Shares Held by All Insider
3.44%% of Shares Held by Institutions
3.66%% of Float Held by Institutions
1Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Nova Mentis Life Science Corp.


Canadian securities regulators publish sixth review regarding women on boards and in executive officer positions

TORONTO, March 10, 2021 - Securities regulatory authorities in Alberta, Manitoba, New Brunswick, Nova Scotia, Ontario, Québec and Saskatchewan (the participating jurisdictions) today published results from the sixth year review of women on boards and in executive officer positions.The notice summarizes results from a review of the disclos... Read More...

BlackBerry AtHoc Introduces Derived Credentials and FedRAMP Authorization on AWS to Better Support U.S. Federal Government’s Cloud and Mobile Strategy

SAN RAMON, Calif., March 9, 2021 -- BlackBerry Limited (NYSE: BB; TSX: BB) today announced new technology advancements to BlackBerry® AtHoc that will improve how U.S. Federal agencies communicate and collaborate during times of crisis, and reduce the risk of unauthorized access to Federal data, systems and applications. BlackBerry AtHoc, ... Read More...

Media Advisory – Caisse de dépôt et placement du Québec — financial results for 2020

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Feb. 9, 2021 - Eclipse Gold Mining Corporation ("Eclipse") (TSXV: EGLD) (OTC: EGLPF) and Northern Vertex Mining Corp. ("Northern Vertex") (TSXV: NEE) (OTC-NASDAQ Intl: NHVCF) are pleased to announce that Eclipse has received ... Read More...

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

VANCOUVER, BC, Feb. 18, 2021 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a leader in the development of serotonergic psychedelic compounds, is pleased to announce that the Company is expanding its pre-clinical program to develop a novel diagnostic and treatment approach to fragile X s... Read More...

Eclipse Gold Receives Final Court Order Approving Plan of Arrangement with Northern Vertex and Announces Security Holder Voting Results

VANCOUVER, BC, Jan. 13, 2021 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Julia V. Perederiy, PhD to its Scientific Advisory Board, effective immediately.Nova Mentis Life Science Corp. (CNW Group/Nova Mentis Life Science Corp.)Specializing in early-stage ... Read More...

Nova Mentis Expands Psychedelic Drug Pipeline

VANCOUVER, BC, Dec. 29, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio. NOVA has contracted with its U.S. partner to begin manufacturing the active pharmaceutical ingredients (API), baeocystin and aeru... Read More...

Think Research Corporation Announces Grant of Equity Compensation and Appointment of Chief Operating Officer

TORONTO, Dec. 22, 2020 - Eastwood Capital Corp. (the "Acquiror") has today filed an early warning report (the "Early Warning Report") advising of its acquisition of an aggregate of 2,211,400 common shares (the "Shares") of Automotive Finco Corp. (the "Company") through a private transaction. The Shares were purchased at a price of $1.50 p... Read More...

Early Warning Report for Eastwood Capital Corp.

VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...

Historic Expansion of Agriculture Irrigation Infrastructure Reaches Financial Close

Investment will create jobs, expand agriculture production and grow the Alberta economyTORONTO, Dec. 21, 2020 - The Canada Infrastructure Bank (CIB), Alberta's government and eight irrigation districts have formalized an agreement for the Alberta Irrigation Project with the CIB investing $407.5 million.The Alberta government will contribu... Read More...

Canada and Ontario invest in green infrastructure to support residents of Pays Plat First Nation and Biigtigong Nishnaabeg First Nation

VANCOUVER, BC, Dec. 3, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Marvin S. Hausman, MD as Chairman of its Scientific Advisory Board, effective immediately. Dr. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiar... Read More...

Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

VANCOUVER, BC, Dec. 3, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Marvin S. Hausman, MD as Chairman of its Scientific Advisory Board, effective immediately. Dr. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiar... Read More...

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Provides Corporate Update

VANCOUVER, BC, Nov. 11, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has provided a corporate update.Dr. Marvin S. Hausman MD, Chairman and Chief Scientific Officer of Pilz commented: "We are very pleased wi... Read More...

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement

VANCOUVER, BC, Nov. 5, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has entered into a psilocybin manufacturing agreement with a U.S. based pharmaceutical company with over 800 employees. Pilz will have comp... Read More...

Nova Mentis Life Science Signs Amalgamation Agreement to Acquire 100% of Pilz BioScience Corp.

VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...

Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

VANCOUVER, BC , July 8, 2020 - Nova Mentis Life Science Corp. (NOVA.CN) (HN3Q.F) (LIBFD) ("NOVA") is pleased to announce Mr. Robert W.E. Laurie has been re-appointed Advisory Board Chair and additionally appointed Psychedelics Regulatory Advisor.Robert W.E. Laurie is an international lawyer, qualified in England and called to the British ... Read More...
Coming Soon.

Delayed data (1h)
NameAgePositionAppointed
William Rascan
President, Chief Executive Officer, Director
--President, Chief Executive Officer, Director2012
Jamie Robinson
Chief Financial Officer
--Chief Financial Officer2017
Steven Feldman
Independent Director
--Independent Director2012
Doug Macdonell
Independent Director
--Independent Director2017


Share this page